Mark DuVal is President of DuVal & Associates, where he counsels both mature and venture-backed pharmaceutical, medical device, biotech, food and nutritional supplement companies in the United States and Europe. Mr. DuVal also works extensively with combination products. He regularly advises clients in all areas of FDA law and regulation, from product development, clinical trials, inspections and recalls to reimbursement and compliance issues and post-marketing responsibilities. Mr. DuVal specializes in counseling medical device and pharmaceutical companies in the development and implementation of strategic and tactical sales and marketing plans that are appropriately aggressive, yet compliant.
Prior to founding DuVal & Associates, P.A., Mr. DuVal was general counsel for 3M Pharmaceuticals and 3M Drug Delivery Systems for almost fifteen years. He also worked in the United Kingdom on a Pan-European assignment as general counsel for 3M Health Care, Ltd. Upon returning from Europe, Mr. DuVal was recruited by Medtronic, where he worked in Corporate Regulatory Compliance Services. While at Medtronic, Mr. DuVal was responsible for FDA, Anti-kickback, False Claims Act and antitrust advice for business units and their lawyers.